---
title: "Xenetic Biosciences (XBIO.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/XBIO.US/norm.md"
symbol: "XBIO.US"
name: "Xenetic Biosciences"
parent: "https://longbridge.com/zh-CN/quote/XBIO.US.md"
datetime: "2026-05-22T01:49:06.366Z"
locales:
  - [en](https://longbridge.com/en/quote/XBIO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/XBIO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/XBIO.US/norm.md)
---

# Xenetic Biosciences (XBIO.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2000 | -0.2656 | -0.3307 | -0.4466 | -0.5856 |
| ROE | -25.45% | -40.82% | -48.55% | -57.57% | -64.93% |
| 营业收入 | 806923.00 | 766296.00 | 1.03M | 589897.00 | 593261.00 |
| 净利润 | -456382.00 | -579076.00 | -509940.00 | -688703.00 | -903141.00 |
| 营业利润 | -502117.00 | -623027.00 | -544734.00 | -724412.00 | -942409.00 |
| 毛利率 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| 净利率 | -56.56% | -75.57% | -49.66% | -116.75% | -152.23% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 7.91M | 8.36M | 5.07M | 5.35M | 5.79M |
| 权益乘数 | 1.14 | 1.13 | 1.28 | 1.20 | 1.13 |
| 每股净资产 | 3.03 | 3.23 | 2.56 | 2.88 | 3.32 |
| 资产周转率 | 0.4657 | 0.3900 | 0.4360 | 0.3401 | 0.3402 |
| 现金及短投 | 7.35M | 7.88M | 4.12M | 4.78M | 5.16M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | - | - | - | - |
| 净债务 | -7.35M | -7.88M | -4.12M | -4.78M | -5.16M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -536377.00 | -242682.00 | -658247.00 | -383830.00 | -1.00M |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | - | 4.00M | - | - | - |
| 自由现金流 | -398475.00 | 254268.00 | -488766.00 | -461806.00 | -687757.00 |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |